Precision Health Research, the lead entity implementing Singapore’s National Precision Medicine strategy, has teamed up with genomics technology firm Illumina, for a large-scale population study on diseases relevant to Asian people.
The project, titled SG100K, will sequence and analyse the genomes of about 100,000 consenting participants around Singapore with Chinese, Malay, and Indian backgrounds, representing about 80% of the population…